Literature DB >> 1366592

Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium.

H Miyaji1, T Mizukami, S Hosoi, S Sato, N Fujiyoshi, S Itoh.   

Abstract

A Namalwa cell line, KJM-1, which was adapted to serum-free medium is thought to be a very useful host cell line for recombinant DNA technology. Thus, the utility of Namalwa KJM-1 for expression of foreign genes was examined. As a model system human beta-interferon (beta-IFN) gene was engineered for expression in this cell line. For construction of the beta-IFN expression vector pSE1 beta 1-4, the expression vector pAGE107 was constructed and used. It contains simian virus 40 (SV40) early promoter, the rabbit beta-globin RNA processing signals for splicing and polyadenylation, and SV40 early RNA processing signal for polyadenylation. In addition to the above transcription unit, pAGE107 contains the ampicillin-resistance gene and G418-resistance gene. They can confer ampicillin resistance to Escherichia coli (E. coli) and G418 resistance to animal cells. To introduce plasmid DNA into cells, electroporation is a useful method (Wong, 1982; Potter, 1984). We have established conditions for DNA-mediated transfection of Namalwa KJM-1 cell line by electroporation. Among pSE1 beta 1-4-introduced cells, clone 1-3 was further examined for the expression of beta-IFN in serum-free medium. The production level of beta-IFN was elevated with the increase of the cell density. The results indicated that the Namalwa KJM-1 cell line is useful for production of foreign gene products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366592     DOI: 10.1007/bf00143675

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

1.  A new SV40-based vector developed for cDNA expression in animal cells.

Authors:  T Mizukami; S Itoh
Journal:  J Biochem       Date:  1987-05       Impact factor: 3.387

2.  Establishment of stable mouse myeloma cells constitutively secreting human tissue-type plasminogen activator.

Authors:  U H Weidle; P Buckel
Journal:  Gene       Date:  1987       Impact factor: 3.688

3.  Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells.

Authors:  F Toneguzzo; A C Hayday; A Keating
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

4.  The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes.

Authors:  H Dorai; G P Moore
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

5.  Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase.

Authors:  K O'Hare; C Benoist; R Breathnach
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  Electric field mediated gene transfer.

Authors:  T K Wong; E Neumann
Journal:  Biochem Biophys Res Commun       Date:  1982-07-30       Impact factor: 3.575

7.  Structure of a chromosomal gene for human interferon beta.

Authors:  S Ohno; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; A J Spiliotes; S D Gossels; S A Latt; G R Larsen; R M Kay
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

10.  Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein.

Authors:  H R Gralnick; S B Williams; M E Rick
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  7 in total

1.  Adaptation of mammalian cells to growth in serum-free media.

Authors:  M S Sinacore; D Drapeau; S R Adamson
Journal:  Mol Biotechnol       Date:  2000-07       Impact factor: 2.695

2.  Optimization of cell culture conditions for production of biologically active proteins.

Authors:  S Hosoi; H Miyaji; M Satoh; T Kurimoto; A Mihara; N Fujiyoshi; S Itoh; S Sato
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  Optimization of cell culture conditions for G-CSF (granulocyte-colony stimulating factor) production by genetically engineered Namalwa KJM-1 cells.

Authors:  S Hosoi; K Murosumi; K Sasaki; M Satoh; H Miyaji; M Hasegawa; S Itoh; T Tamaoki; S Sato
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

4.  Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapted to serum-free medium by a dhfr gene coamplification method.

Authors:  H Miyaji; N Harada; T Mizukami; S Sato; N Fujiyoshi; S Itoh
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

5.  Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium.

Authors:  H Miyaji; N Harada; T Mizukami; S Sato; N Fujiyoshi; S Itoh
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

6.  KW-3902, a selective high affinity antagonist for adenosine A1 receptors.

Authors:  H Nonaka; M Ichimura; M Takeda; T Kanda; J Shimada; F Suzuki; H Kase
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

7.  A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities.

Authors:  K Shitara; Y Kuwana; K Nakamura; Y Tokutake; S Ohta; H Miyaji; M Hasegawa; N Hanai
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.